Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-demand MeteoSpasmyl for irritable bowel syndrome
2009-013049-27Phase 4Completed
- Sponsor
- Mayoly Spindler
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of alverine citrate + simeticone, alverine and simethicone in irritable bowel syndrome (IBS) (2 arms), sponsored by Mayoly Spindler. Primary endpoint: Primary utility endpoint. Started Sep 2009; status: completed.
02
Drugs
alverine citrate + simeticonealverinesimethicone
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2009-013049-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013049-27.